We are Genomics England and our vision is to create a world where everyone benefits from genomic healthcare. Introducing our refreshed podcast identity: Behind the Genes, previously known as The G Word. Join us every fortnight, where we cover everything from the latest in cutting-edge research to real-life stories from those affected by rare conditions and cancer. With thoughtful conversations, we take you behind the science. You can also tune in to our Genomics 101 explainer series which breaks down complex terms in under 10 minutes.
Episodes
Wednesday Sep 28, 2022
Professor Matthew Hurles: The Sherlock Holmes moment
Wednesday Sep 28, 2022
Wednesday Sep 28, 2022
The genome itself was the beginning of a whole technological revolution. Matt and Chris talk about taking on the challenge, searching for the needle in the haystack, and making it work at scale! Join Chris and population geneticist Prof Matthew Hurles this week as they delve into the genetic detective work and the future of research while engaging the research and participant community. If you're a student wanting to get into the field, Matt gives his take on how to go about it.
You can find our transcript here – https://files.genomicsengland.co.uk/documents/Podcast-transcripts/Matthew-Hurles.docx.
“The reference datasets of normal population variation in individuals of African ancestry are just smaller, and therefore less powerful than the ones of European ancestry. What we really need to do is enrich those African ancestry population datasets, that's something we really can hit on. I think that's a real global challenge."
Prof Matt Hurles is Head of Human Genetics at the Wellcome Sanger Institute and Senior Group Leader of The Hurles Group. He is also the founder of Congenica and an honorary professor of Human Genetics and Genomics at the University of Cambridge. He leads the Deciphering Developmental Disorders (DDD) Study and the Prenatal Assessment of Genomes and Exomes (PAGE) Study. He also led the DECIPHER initiative that is enabling rare disease patients to share anonymised genetic and clinical data globally.